Merlano M - Search Results

1

Combination of bevacizumab and irradiation on uveal melanoma: an in vitro and in vivo preclinical study.

Sudaka A, Susini A, Lo Nigro C, Fischel JL, Toussan N, Formento P, Tonissi F, Lattanzio L, Russi E, Etienne-Grimaldi MC, Merlano M, Milano G. Sudaka A, et al. Among authors: merlano m. Invest New Drugs. 2013 Feb;31(1):59-65. doi: 10.1007/s10637-012-9834-6. Epub 2012 Jun 20. Invest New Drugs. 2013. PMID: 22714791

2

The cisplatin-irradiation combination suggests that apoptosis is not a major determinant of clonogenic death.

Lo Nigro C, Arnolfo E, Taricco E, Fruttero A, Russi EG, Lucio F, Ribero S, Comino A, Merlano M, Ungari S. Lo Nigro C, et al. Among authors: merlano m. Anticancer Drugs. 2007 Jul;18(6):659-67. doi: 10.1097/CAD.0b013e328087388f. Anticancer Drugs. 2007. PMID: 17762394

3

The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data.

Lo Nigro C, Maffi M, Fischel JL, Formento P, Milano G, Merlano M. Lo Nigro C, et al. Among authors: merlano m. BJU Int. 2008 Aug 5;102(5):622-7. doi: 10.1111/j.1464-410X.2008.07706.x. Epub 2008 May 20. BJU Int. 2008. PMID: 18494832

4

Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: "Koebner-Phenomenon" or radio-dermatitis?

Merlano MC, Russi EG. Merlano MC, et al. Radiother Oncol. 2009 Jul;92(1):142-3. doi: 10.1016/j.radonc.2009.03.001. Epub 2009 Mar 26. Radiother Oncol. 2009. PMID: 19328573 No abstract available.

5

Impact of erythropoietin on the effects of irradiation under hypoxia.

Lo Nigro C, Maffi M, Fischel JL, Monteverde M, Catarsi P, Tonissi F, Lattanzio L, Riba M, Etienne-Grimaldi MC, Formento P, Milano G, Merlano M. Lo Nigro C, et al. Among authors: merlano m. J Cancer Res Clin Oncol. 2009 Nov;135(11):1615-23. doi: 10.1007/s00432-009-0609-1. Epub 2009 Jun 5. J Cancer Res Clin Oncol. 2009. PMID: 19499245

6

Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer.

Lo Nigro C, Monteverde M, Riba M, Lattanzio L, Tonissi F, Garrone O, Heouaine A, Gallo F, Ceppi M, Borghi F, Comino A, Merlano M. Lo Nigro C, et al. Among authors: merlano m. Int J Oncol. 2010 Nov;37(5):1219-28. doi: 10.3892/ijo_00000773. Int J Oncol. 2010. PMID: 20878069

7

Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.

Pinto C, Barone CA, Girolomoni G, Russi EG, Merlano MC, Ferrari D, Maiello E; American Society of Clinical Oncology; European Society of Medical Oncology. Pinto C, et al. Oncologist. 2011;16(2):228-38. doi: 10.1634/theoncologist.2010-0298. Epub 2011 Jan 27. Oncologist. 2011. PMID: 21273511 Free PMC article.

8

Russi EG, Numico G, Merlano MC, Pinto C. Russi EG, et al. Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1278; author reply 1278-9. doi: 10.1016/j.ijrobp.2010.10.047. Int J Radiat Oncol Biol Phys. 2011. PMID: 21353162 No abstract available.

9

Combination of docetaxel and vandetanib in docetaxel-sensitive or resistant PC3 cell line.

Monteverde M, Tonissi F, Fischel JL, Etienne-Grimaldi MC, Milano G, Merlano M, Lo Nigro C. Monteverde M, et al. Among authors: merlano m. Urol Oncol. 2013 Aug;31(6):776-86. doi: 10.1016/j.urolonc.2011.03.018. Epub 2011 Jul 27. Urol Oncol. 2013. PMID: 21795074

10

Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions.

Denaro N, Russi EG, Adamo V, Colantonio I, Merlano MC. Denaro N, et al. Oncology. 2011;81(1):21-9. doi: 10.1159/000330818. Epub 2011 Sep 8. Oncology. 2011. PMID: 21912194 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters